3-year follow-up after partial cardiac denervation during bypass surgery for coronary artery disease
Follows people 3 years after bypass surgery to see heart outcomes.
Plain-language title generated from the registry record
Registry title: pCAD-POAF 3 Year Follow-up
Key facts
- Where
- Beijing, ChinaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people who already took part in the pCAD-POAF trial (NCT05009914). It follows them for 3 years after their heart surgery.
- Age
- 18 Years to 85 Years
- Sex
- All sexes can join.
- Earlier treatment
- Must have taken part in the pCAD-POAF trial before.
Main reasons for not taking part
- People who did not take part in the pCAD-POAF trial cannot join.
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Source: NCT07146061, who can take part
Where in China
- Fuwai Hospital ，CAMS&PUMCBeijing, ChinaContact: Wei Feng, MDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- China National Center for Cardiovascular Diseases
- Trial code
- NCT07146061
- Record updated
- 1 October 2026
- Original description
This study will include the subjects who enrolled in pCAD-POAF trial (NCT05009914) to observe clinical outcomes 3 years after surgery.Read full original descriptionShow less
Partial Cardiac Denervation to Prevent POAF After CABG: 3 Year Follow-up of pCAD-POAF Randomized Trial
This study will include the subjects who enrolled in pCAD-POAF trial (NCT05009914) to observe clinical outcomes 3 years after surgery.
The primary outcome is the time to first occurrence of a composite of all-cause death, stroke, systemic embolism, myocardial infarction, unplanned cardiac rehospitalization, or post-discharge atrial fibrillation from randomization through 3 years after surgery.
The secondary outcomes are：the individual components of the primary composite outcome; unplanned all-cause rehospitalization; arrhythmias other than atrial fibrillation; premature atrial contraction and premature ventricular contraction burdens; heart rate variability parameters; quality-of-life scores; and other Holter-derived parameters.
Inclusion: This study will include the subjects who enrolled in pCAD-POAF trial.
Exclusion: This study will include the subjects who enrolled in pCAD-POAF trial.